Mpox-Related Knowledge, Risk Perception, and Vaccination Willingness Among University Students in Aktobe, Kazakhstan: A Cross-Sectional Study

Dilnaz Konbayeva, Кутумбетов Леспек Бекболатович, Balzhan Sh. Myrzakhmetova, Olga V. Chervyakova, Kuandyk D. Zhugunissov, Askhat Myngbay, Gulnar Altayeva, Saida Askatkyzy, Togzhan Nurdauletova, Gulmira Abulgazimova

2 more authors

Nadezhda Burambayeva, Arman Issimov

Vaccines, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/vaccines14060504
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

BACKGROUND: Mpox is a re-emerging viral zoonotic disease that remains relevant for public health preparedness, risk communication, and vaccination literacy. University students are an important population for infectious disease communication because they are socially active, digitally connected, and may act as knowledge multipliers. This study assessed Mpox-related knowledge, risk perception, preventive practices, and willingness to receive Mpox vaccination among university students in Aktobe, Kazakhstan, and identified independent predictors of adequate knowledge and vaccination willingness. METHODS: A cross-sectional questionnaire-based survey was conducted among students from three universities. The questionnaire collected socio-demographic characteristics, Mpox-related knowledge, information sources, attitudes, preventive practices, perceived risk, and vaccination willingness. Knowledge was summarized using a three-item score; adequate knowledge was defined as a score of at least 2 out of 3. Two multivariable logistic regression models were fitted: one for adequate Mpox-related knowledge and one for willingness to receive Mpox vaccination. RESULTS: The final descriptive dataset included 482 respondents. Most participants were female (66.8%), from urban areas (80.5%), and aged 17-18 years (61.6%). Only 217 students (45.0%) had previously heard about Mpox, 193 (40.0%) correctly identified rash as the main symptom, and 179 (37.1%) knew that vaccination against Mpox exists. Adequate knowledge was observed in 201 students (41.7%), while only 150 students (31.1%) were willing to receive Mpox vaccination. In the multivariable model, adequate knowledge was independently associated with studying at Marat Ospanov West Kazakhstan Medical University (aOR = 5.66; 95% CI: 2.95-10.84), use of medical websites as an information source (aOR = 1.71; 95% CI: 1.09-2.69), and following infectious disease news (aOR = 2.81; 95% CI: 1.76-4.48). Vaccination willingness was independently associated with considering Mpox a dangerous infectious disease (aOR = 2.04; 95% CI: 1.11-3.77) and perceiving Mpox as a threat to Kazakhstan (aOR = 2.16; 95% CI: 1.30-3.59). CONCLUSIONS: Mpox-related knowledge among university students in Aktobe was limited, while vaccination willingness remained low despite moderate perceived risk. Reliable information exposure improved knowledge, whereas vaccination willingness was more strongly associated with perceived disease threat. These findings support university-based health literacy, vaccine literacy, and risk communication interventions aimed at improving preparedness for emerging infectious diseases.